Ascletis Pharma Inc.

About Us
Corporate Overview Management Team Board of Directors Contact Us
Our Focus
Viral Diseases NASH/PBC Cancer Exploratory Indications
Products&Pipeline
Pipeline Products Clinical Trials
Partnership
Investors
Financials & Filing Presentation Materials
News
Careers

Investors

Financials & Filing
Presentation Materials

Next Day Disclosure Returns - Share Buyback
2023-11-20
Next Day Disclosure Returns - Share Buyback
2023-11-16
Next Day Disclosure Returns - Share Buyback
2023-11-15
Next Day Disclosure Returns - Share Buyback
2023-11-14
Voluntary Announcement - Ascletis Announces Poster Presentations at AASLD Annual Meeting 2023 Including a Late-Breaking Abstract of Interim Results from Phase IIb Expansion Cohort of ASC22 for Functional Cure of CHB
2023-11-13
Next Day Disclosure Returns - Share Buyback
2023-11-10
Next Day Disclosure Returns - Share Buyback
2023-11-09
Next Day Disclosure Returns - Share Buyback
2023-11-08
Next Day Disclosure Returns - Share Buyback
2023-11-07
Next Day Disclosure Returns - Share Buyback
2023-11-06

2

© 2018 Ascletis Pharma Inc.

All Rights Reserved

contact

pr@ascletis.com
bd@ascletis.com

hr@ascletis.com
clinicaltrials@ascletis.com

© 2018 Ascletis Pharma Inc. All Rights Reserved
浙公网安备 33010802003344号浙ICP备11050387号-1